Weight loss medications like Zepbound® have become increasingly popular as people seek effective solutions to manage their weight. As it is FDA-approved for treating obesity, Zepbound® can be a powerful tool in achieving your weight loss goals. As with any medication, it's crucial to be aware of potential side effects and understand how to manage them effectively.

This article delves into the side effects of Zepbound®, exploring their causes and discussing treatment options. Whether you're considering Zepbound® for weight loss or currently taking it, this comprehensive guide aims to equip you with the knowledge to navigate your weight loss journey safely and successfully.

An Overview of Zepbound® for Weight Management

Zepbound® uses the active ingredient tirzepatide, also sold under the brand label Mounjaro, to treat type 2 diabetes. Zepbound® has been approved by the FDA for weight loss in individuals struggling with obesity or being overweight. Although it is classified as a GLP-1 agonist, Zepbound® also has a unique mechanism of action by targeting the glucose-dependent insulinotropic polypeptide (GIP) receptor, which enhances its weight loss effects. 

Studies have shown that patients on Zepbound® can lose an average of 7.6 to 11.2 kg (16.8 to 24.7 lbs), depending on the dosage (1, 2). Compared to other GLP-1 medications like Ozempic® or Wegovy®, Zepbound® results in greater weight loss (3). However, to maximize results, it should be used in conjunction with healthy lifestyle changes, including increased physical activity and mindful eating. 

Key Features:

• Drug Type: GIP and GLP-1 receptor agonist (4).

• Indications: For adults with obesity, characterized by a BMI of 30 or greater, or those who are overweight, characterized by a BMI of 27 or greater, with weight-related conditions (e.g., heart disease, high blood pressure, diabetes, obstructive sleep apnea) (4)

• Dosage: Start with 2.5 mg weekly for 4 weeks and then increase to 5 mg. Your provider can raise the dose by 2.5 mg every 4 weeks up to 15 mg (4). 

• Administration: Once weekly self-injection. Clean the injection site (abdomen or thigh) with an alcohol wipe, unlock the pen, and press and hold the button for up to 10 seconds until you hear two clicks, indicating the start and completion of the injection (4). 

Common and Rare Side Effects of Zepbound

Zepbound® is an effective medication for weight loss but can cause side effects. Most gastrointestinal (GI) events reported were mild to moderate, transient, and occurred mostly during the dose-increase phase. Common side effects include:

• Nausea

• Diarrhea

• Vomiting

• Constipation

• Fatigue

• Indigestion

• Hair loss

• Abdominal pain

• Burning, itching, or pain at the injection site

Adverse but rare side effects:

• Acute pancreatitis (inflammation of the pancreas)

• Gallbladder disease (e.g. gallstones)

• Low blood sugar

• Acute kidney injury

• Thyroid cancer, particularly in those with family history

• Severe allergic reactions

Knowing these side effects can help you prepare for and manage them effectively.

Tips for Managing Zepbound® Side Effects

Side effects can be uncomfortable, but there are ways to manage them. Remember to always inform your doctor about any symptoms you experience so they can provide a proper evaluation and guidance. 

• Stay Hydrated: Drink plenty of water, especially if experiencing nausea and vomiting.

• Aromatherapy: Try smelling alcohol wipes or citrus fruit (e.g., lemons, oranges), which can often help with nausea and prevent vomiting.

• Fiber supplementation: Consider eating more foods high in fiber or adding a fiber supplement. Fiber helps absorb water, soften stool, and promote regular bowel movements.

• Small, Frequent Meals: Eat smaller meals more often to manage nausea and indigestion while maintaining an adequate nutrition intake.

• Rotate Injection Sites: Switch up the location to minimize discomfort and skin irritation.

When to Seek Medical Advice For Zepbound® Side Effects

Seek immediate medical attention if you experience severe side effects, including signs of allergic reactions, severe gastrointestinal distress, or symptoms indicating low blood sugar. It's also essential to consult healthcare professionals if you have concerns about the medication's impact on existing health conditions or if you are pregnant.

There may also be alternative medications that are better tolerated in some patients. Your Mochi Health provider can help assess your health history to determine what the right medication and dosage is for you. Explore other medications options here: https://joinmochi.com/medications

Key Takeaways For Managing Zepbound® Side Effects

Zepbound® is a powerful tool for combating obesity and overweight. For those who have struggled with traditional methods of weight loss, Zepbound® provides an alternative path to a healthier you. While it has some side effects, working with your healthcare provider can help you manage them effectively. 

Interested in a comprehensive approach to obesity medicine? Mochi Health tailors weight management programs specifically for you, incorporating medications like Zepbound® with support from licensed physicians and nutrition experts. With medications delivered directly to your door and 24/7 customer support, managing your weight has never been more convenient. Discover how Mochi Health can support your weight management goals. Check your eligibility for our program here.

‍

This post was written by our team of health writers for informational purposes only and does not constitute medical advice. Always consult your doctor or healthcare provider for personalized guidance regarding your health. Ozempic®, Wegovy®, Mounjaro®, and Zepbound® and their delivery device are registered trademarks. Mochi Health is a telehealth clinic that offers prescriptions for these products by medical necessity only as determined by a licensed health provider.

Sources

1. Garvey, W. T., Frias, J. P., Jastreboff, A. M., le Roux, C. W., Sattar, N., Aizenberg, D., Mao, H., Zhang, S., Ahmad, N. N., Bunck, M. C., Benabbad, I., Zhang, X. M., Abalos, F. H., Manghi, F. C. P., Zaidman, C. J., Vico, M. L., Aizenberg, D., Costanzo, P. R., Serra, L. P., … Jones, T. (2023). Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. The Lancet (British Edition), 402(10402), 613–626. https://doi.org/10.1016/S0140-6736(23)01200-X

2. Rebitch, C. B. (2023). Tirzepatide (Mounjaro) for the Treatment of Type 2 Diabetes Mellitus. American Family Physician, 108(1), 93–94.

3. Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., Liu, B., Cui, X., & Brown, K. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. The New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519

4. What is5.  Zepbound® | Zepbound® (tirzepatide). (n.d.). https://Zepbound®.lilly.com/what-is-zepbound

‍